“Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis and Skin of Color”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s549, https://doi.org/10.25251/skin.10.supp.549.